Xenin-25 Amplifies GIP-Mediated Insulin Secretion in Humans With Normal and Impaired Glucose Tolerance but Not Type 2 Diabetes

Glucose-dependent insulinotropic polypeptide (GIP) potentiates glucose-stimulated insulin secretion (GSIS). This response is blunted in type 2 diabetes (T2DM). Xenin-25 is a 25–amino acid neurotensin-related peptide that amplifies GIP-mediated GSIS in hyperglycemic mice. This study determines if xen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wice, Burton M., Reeds, Dominic N., Tran, Hung D., Crimmins, Dan L., Patterson, Bruce W., Dunai, Judit, Wallendorf, Michael J., Ladenson, Jack H., Villareal, Dennis T., Polonsky, Kenneth S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Pathophysiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379667/
https://www.ncbi.nlm.nih.gov/pubmed/22522617
http://dx.doi.org/10.2337/db11-1451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379667/
https://www.ncbi.nlm.nih.gov/pubmed/22522617
http://dx.doi.org/10.2337/db11-1451

Ejemplares similares